Shifting Tides: A Comparison of Penbrook Management LLC's Q4 2022 and Q1 2023 Holdings

Investors and analysts alike are always on the lookout for changes in the holdings of major funds, as these changes can provide insight into the current state of the market and trends that may be emerging.

One such fund is Penbrook Management LLC, whose Q4 2022 and Q1 2023 holdings provide an interesting glimpse into the current state of the market. In this blog post, we will take a closer look at these holdings and analyze the changes that have occurred between the two quarters.

Introduction: Penbrook Management LLC

Penbrook Management LLC is an investment management firm founded in 2012. Based in Pennsylvania, the firm primarily invests in small-cap and mid-cap companies in North America. As of Q1 2023, the firm had over $1 billion in assets under management.

Main Body: A Closer Look at the Holdings

The holdings listed in the CSV file above show the share values and values in dollars of Penbrook Management LLC's Q4 2022 and Q1 2023 holdings. Let's examine some of the major changes that have occurred between the two quarters.

One of the most notable changes is the increase in holdings for the Thomson Reuters Corp New (TRI.TO) stock, with a rise of 12.9% in value. This increase is likely due to the growth of the company in Q1 2023, which saw a rise in revenue and a strong performance in its financial and risk businesses.

Another significant change is the decrease in holdings for the Vermilion Energy Inc (VET.TO) stock, with a drop of 27.6% in value. This drop is likely due to the decline in oil prices in the first quarter of 2023, as well as the company's announcement of a dividend cut in February 2023.

Additionally, the Invacare Corp (IVC) stock was removed from the firm's holdings in Q1 2023, indicating a shift in the firm's investment strategy. This change may have been due to the company's unstable financial performance, which saw a decrease in earnings in Q4 2022.

On the other hand, Telesis Bio Inc (TBIO) saw a significant increase in holdings, with a rise of 229.1% in value. This increase is likely due to the company's announcement of positive clinical trial results for its stem cell therapy in January 2023.

Conclusion: Analyzing the Shifts in Penbrook Management LLC's Holdings

Overall, Penbrook Management LLC's Q4 2022 and Q1 2023 holdings provide insight into the current state of the market and the firm's investment strategy. Through analyzing the changes in the holdings of different stocks, we can see the shifts in the market and the emerging trends that may be worth paying attention to.

As always, it's important to keep in mind that these changes only represent one firm's investment strategy and may not be reflective of the market as a whole. However, by staying up to date on changes like these, investors and analysts can make more informed decisions about their own investments.